UNSPSC 51284605: Meropenem

This classification denotes a beta-lactam antibiotic with the molecular formula C17H25N3O5S.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FV9J3JU8B1, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, trihydrate, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as meropenem, which bears US NIH Compound Identifier 60706.

UNSPSC 51284605 Meropenem is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect meropenem procurement. Instead, the tagged opportunities center on other pharmaceutical products — naloxone for opioid overdose response and antibiotic tablets (doxycycline hyclate and ciprofloxacin hydrochloride) procured through piggyback and direct-purchase vehicles. State and local governments buying under this code tier are acquiring branded or generic pharmaceutical inventory through cooperative purchasing agreements, piggyback contracts, and competitive bidding. Issuing bodies include state health departments and county governments; the opportunities show both statewide consolidated purchasing (Illinois Department of Public Health through the MMCAP Infuse cooperative) and county-level direct procurement (Seminole County, Florida).

Recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride tablets under IFB 26482DPHPREPDB53392, posted August 28, 2026 with a response deadline of September 11, 2026; the contract covers a 12-month initial term with renewal options for years 2 and 3. Seminole County, Florida issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, posted June 30, 2026 with a response deadline of July 26, 2023. The mismatch between the code's nominal scope (meropenem) and the actual recent opportunities (other pharmaceuticals) suggests limited or miscoded activity directly under this specific Commodity code.